Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Raizer · SciRah

Researcher profile · Semantic Scholar

J. Raizer

Share profile

J. Raizer — researcher profile on SciRah

h-index: 56
Works: 286
Citations: 12K

Most-cited papers

Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao, Andrew X. Chen, R. Gartrell, A. Silverman +23 more
2019Nature Medicine818 citations Open access
Semantic Scholar
MENINGIOMAS
Leland Rogers, Igor J. Barani, M. Chamberlain, T. Kaley +6 more
2015Journal of Neurosurgery304 citations Open access
Semantic Scholar
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group.
Raymond Y. Huang, W. Bi, M. Weller, T. Kaley +14 more
2018Neuro-Oncology191 citations Open access
Semantic Scholar
NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
C. Tsien, S. Pugh, A. Dicker, J. Raizer +13 more
2022Journal of Clinical Oncology161 citations Open access
Semantic Scholar
Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications
A. Boire, D. Brandsma, P. Brastianos, É. Le Rhun +14 more
2019Neuro-Oncology147 citations Open access
Semantic Scholar
Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas.
M. Drumm, K. Dixit, S. Grimm, P. Kumthekar +12 more
2019Neuro-Oncology88 citations Open access
Semantic Scholar
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma
E. Ladomersky, Li-Jie Zhai, Kristen L. Lauing, A. Bell +21 more
2020Clinical Cancer Research84 citations Open access
Semantic Scholar
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer
R. Malani, M. Fleisher, P. Kumthekar, Xuling Lin +13 more
2020Journal of Neuro-Oncology75 citations Open access
Semantic Scholar
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients
J. Raizer, P. Giglio, Jethro L. Hu, M. Groves +19 more
2016Journal of Neuro-Oncology74 citations Open access
Semantic Scholar
Faculty Opinions recommendation of CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014.
J. Raizer
201872 citations Open access
Semantic Scholar
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2–Positive Gastric or Gastroesophageal Junction Adenocarcinoma
S. Klempner, Keun-Wook Lee, K. Shitara, J. Metges +12 more
2023Clinical Cancer Research66 citations Open access
Semantic Scholar
A Phase I/II Study of Intrathecal Trastuzumab in HER-2 Positive Cancer with Leptomeningeal Metastases: Safety, Efficacy, and Cerebrospinal Fluid Pharmacokinetics.
P. Kumthekar, M. Avram, A. Lassman, N. Lin +14 more
2022Neuro-Oncology65 citations
Semantic Scholar
A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma
P. Kumthekar, S. Grimm, Roxanne T. Aleman, M. Chamberlain +9 more
2022Neuro-Oncology Advances44 citations Open access
Semantic Scholar
Recent advances in managing/understanding meningioma
Nawal Shaikh, K. Dixit, J. Raizer
2018F1000Research41 citations Open access
Semantic Scholar
Author Correction: Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao, Andrew X. Chen, R. Gartrell, A. Silverman +23 more
2019Nature Medicine40 citations Open access
Semantic Scholar
Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205): Initial Outcomes and RT Plan Quality Report
C. Tsien, S. Pugh, A. Dicker, J. Raizer +13 more
2019International Journal of Radiation Oncology, Biology, Physics38 citations Open access
Semantic Scholar
Primary Central Nervous System Lymphoma-PART 1: Epidemiology, Diagnosis, Staging, and Prognosis.
R. Lukas, R. Stupp, V. Gondi, J. Raizer
2018Oncology38 citations
Semantic Scholar
A phase II trial evaluating the effects and intra-tumoral penetration of bortezomib in patients with recurrent malignant gliomas
J. Raizer, J. Chandler, R. Ferrarese, S. Grimm +7 more
2016Journal of Neuro-Oncology38 citations
Semantic Scholar
Anticonvulsant prophylaxis and steroid use in adults with metastatic brain tumors: summary of SNO and ASCO endorsement of the Congress of Neurological Surgeons guidelines*
Susan M. Chang, H. Messersmith, M. Ahluwalia, D. Andrews +14 more
2019Neuro-Oncology35 citations Open access
Semantic Scholar
Response assessment of meningioma: 1D, 2D, and volumetric criteria for treatment response and tumor progression
Raymond Y. Huang, Prashin Unadkat, W. Bi, E. George +14 more
2018Neuro-Oncology33 citations Open access
Semantic Scholar
Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models
A. Ugolkov, W. Qiang, G. Bondarenko, D. Procissi +8 more
2017Translational Oncology33 citations Open access
Semantic Scholar
Differential Response of Glioma Stem Cells to Arsenic Trioxide Therapy Is Regulated by MNK1 and mRNA Translation
J. Bell, F. Eckerdt, Harshil Dhruv, D. Finlay +17 more
2017Molecular Cancer Research32 citations Open access
Semantic Scholar
Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient
Nu T. Lu, J. Raizer, E. Peter Gabor, Natalie M. Liu +3 more
2015Journal of Immunotherapy for Cancer32 citations Open access
Semantic Scholar
Newer Strategies for the Management of Low-Grade Gliomas.
K. Dixit, J. Raizer
2017Oncology31 citations
Semantic Scholar
ATIM-14. ALLIANCE A071101: A PHASE II RANDOMIZED TRIAL COMPARING THE EFFICACY OF HEAT SHOCK PROTEIN PEPTIDE COMPLEX-96 (HSPPC-96) VACCINE GIVEN WITH BEVACIZUMAB VERSUS BEVACIZUMAB ALONE IN THE TREATMENT OF SURGICALLY RESECTABLE RECURRENT GLIOBLASTOMA
O. Bloch, Q. Shi, S. Anderson, M. Knopp +12 more
201729 citations Open access
Semantic Scholar
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma
Alissa A. Thomas, L. Abrey, R. Terziev, J. Raizer +24 more
2017Neuro-Oncology29 citations Open access
Semantic Scholar
Anticonvulsant Prophylaxis and Steroid Use in Adults With Metastatic Brain Tumors: ASCO and SNO Endorsement of the Congress of Neurological Surgeons Guidelines.
Susan M. Chang, H. Messersmith, M. Ahluwalia, D. Andrews +14 more
2019Journal of Clinical Oncology28 citations Open access
Semantic Scholar
Risk factors for the development of paclitaxel‐induced neuropathy in breast cancer patients
Jetter Robertson, J. Raizer, J. Hodges, W. Gradishar +1 more
2018Journal of the peripheral nervous system28 citations
Semantic Scholar
CODEL (Alliance-N0577; EORTC-26081/22086; NRG-1071; NCIC-CEC-2): Phase III Randomized Study of RT vs. RT+TMZ vs. TMZ for Newly Diagnosed 1p/19q-Codeleted Anaplastic Oligodendroglial Tumors. Analysis of Patients Treated on the Original Protocol Design (PL02.005)
K. Jaeckle, M. Vogelbaum, K. Ballman, S. Anderson +15 more
2016Neurology24 citations
Semantic Scholar
Phase 1b/2 study of pexidartinib (PEX) in combination with radiation therapy (XRT) and temozolomide (TMZ) in newly diagnosed glioblastoma.
H. Colman, J. Raizer, T. Walbert, S. Plotkin +12 more
201817 citations
Semantic Scholar
ACTR-32. NRG ONCOLOGY RTOG 1205: RANDOMIZED PHASE II TRIAL OF CONCURRENT BEVACIZUMAB AND RE-IRRADIATION VS. BEVACIZUMAB ALONE AS TREATMENT FOR RECURRENT GLIOBLASTOMA
C. Tsien, S. Pugh, A. Dicker, J. Raizer +13 more
2019Neuro-Oncology15 citations Open access
Semantic Scholar
Improving vaccine efficacy against malignant glioma
E. Ladomersky, M. Genet, Li-Jie Zhai, G. Gritsina +9 more
2016Oncoimmunology15 citations Open access
Semantic Scholar
LPTO-02. INTRATHECAL (IT) TRASTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL DISEASE (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL RECEPTOR-2 POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY
P. Kumthekar, A. Lassman, N. Lin, S. Grimm +6 more
2019Neuro-Oncology Advances13 citations Open access
Semantic Scholar
A phase I evaluation of intravenous (IV) 131I-chlorotoxin delivery to solid peripheral and intracranial tumors.
T. Gribbin, N. Senzer, J. Raizer, Sui Shen +3 more
2016Journal of Clinical Oncology13 citations
Semantic Scholar
A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas
K. Dixit, S. Sachdev, C. Amidei, P. Kumthekar +9 more
2021Journal of Neuro-Oncology10 citations
Semantic Scholar
Phase II study of zolbetuximab plus pembrolizumab in claudin 18.2: Positive locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma (G/GEJ)—ILUSTRO Cohort 3.
S. Klempner, J. Ajani, S. Al-Batran, Y. Bang +12 more
202110 citations
Semantic Scholar
OS10.6 Infigratinib (BGJ398) in patients with recurrent gliomas with fibroblast growth factor receptor (FGFR) alterations: a multicenter phase II study
A. Lassman, J. Sepúlveda-Sánchez, T. Cloughesy, J. Gil-Gil +12 more
2019Neuro-Oncology10 citations Open access
Semantic Scholar
CMET-22. INTRATHECAL (IT) TRAZTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY
P. Kumthekar, W. Gradishar, Nancy U. Lin, E. Pentsova +6 more
2018Neuro-Oncology8 citations Open access
Semantic Scholar
MNGO-04PHASE II TRIAL OF BEVACIZUMAB IN PATIENTS WITH SURGERY AND RADIATION REFRACTORY PROGRESSIVE MENINGIOMA
S. Grimm, P. Kumthekar, M. Chamberlain, D. Schiff +5 more
20158 citations Open access
Semantic Scholar
Primary Central Nervous System Lymphoma-PART 2: Modern Therapeutic Management and Future Directions.
R. Lukas, V. Gondi, R. Stupp, J. Raizer
2018Oncology7 citations
Semantic Scholar
Impact of treatment variability on survival in immuno‐competent and immuno‐compromised patients with primary central nervous lymphoma
Reem Karmali, C. Nabhan, A. Petrich, J. Raizer +6 more
2017British Journal of Haematology7 citations
Semantic Scholar
Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial
M. Chamberlain, H. Colman, Bryan T. Kim, J. Raizer
2017Journal of Neuro-Oncology7 citations
Semantic Scholar
CTNI-29. CODEL: PHASE III TRIAL OF RT ALONE, RT PLUS TMZ, OR TMZ ALONE FOR NEWLY-DIAGNOSED, 1p/19q CODELETED ANAPLASTIC OLIGODENDROGLIOMA. ANALYSIS FROM THE INITIAL STUDY DESIGN. (NCCTG N0577, ALLIANCE)
K. Jaeckle, K. Ballman, M. J. van den Bent, C. Giannini +19 more
20205 citations Open access
Semantic Scholar
A phase II trial of bevacizumab in patients with recurrent solid tumor brain metastases who have failed whole brain radiation therapy (WBRT).
P. Kumthekar, K. Dixit, S. Grimm, R. Lukas +5 more
2019Journal of Clinical Oncology5 citations
Semantic Scholar
ATIM-11. PHASE 2 TRIAL OF SL-701, A NOVEL IMMUNOTHERAPY COMPRISED OF SYNTHETIC SHORT PEPTIDES AGAINST GBM TARGETS IL-13Rα2, EphA2, AND SURVIVIN, IN ADULTS WITH SECOND-LINE RECURRENT GBM: INTERIM RESULTS
D. Reardon, D. Peereboom, B. Nabors, K. Fink +19 more
20165 citations Open access
Semantic Scholar
Cerebrospinal fluid circulating tumor cells (CSF CTC) for real-time patient monitoring and response to treatment.
R. Malani, M. Fleisher, Xuling Lin, A. Omuro +9 more
20174 citations
Semantic Scholar
Prognosis of older patients with low-grade glioma: A retrospective study
P. Kumthekar, Vaibhav Patel, C. Bridge, A. Rademaker +6 more
2017Integrative Cancer Science and Therapeutics4 citations Open access
Semantic Scholar
The Impact of Perioperative Arterial Infarct on Recurrence, Functional Outcomes, and Survival in Glioblastoma Patients
Jakob T. Lupa, J. Raizer, I. Helenowski, Benjamin P. Liu +2 more
2020Frontiers in Oncology3 citations Open access
Semantic Scholar
QOLP-25. QUALITY OF LIFE FOLLOWING RE-IRRADIATION FOR RECURRENT HIGH GRADE GLIOMA
C. Amidei, K. Dixit, P. Kumthekar, T. Kruser +9 more
2018Neuro-Oncology3 citations Open access
Semantic Scholar
Phase I, open-label ascending dose trial of anti-CTLA-4 monoclonal antibody AGEN1884 in advanced solid malignancies, with expansion to patients refractory to recent anti-PD-1/PD-L1 therapy.
B. Wilky, P. Kumthekar, R. Wesolowski, Jimmy J. Hwang +16 more
2018Annals of Oncology2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Kumthekar×16
Invite
P. Kumthekar — researcher profile on SciRah
S. Grimm×13
Invite
S. Grimm — researcher profile on SciRah
R. Lukas×11
Invite
R. Lukas — researcher profile on SciRah
D. Schiff×8
Invite
D. Schiff — researcher profile on SciRah

×8

Invite

K. Dixit — researcher profile on SciRah

Invite

A. Lassman — researcher profile on SciRah

M. Vogelbaum×7

Invite

M. Vogelbaum — researcher profile on SciRah

Invite

M. Groves — researcher profile on SciRah

Invite

F. Iwamoto — researcher profile on SciRah

Invite

P. Wen — researcher profile on SciRah

C. Horbinski×5

Invite

C. Horbinski — researcher profile on SciRah

M. J. van den Bent×5

Invite

M. J. van den Bent — researcher profile on SciRah